You have 9 free searches left this month | to do more
Showing 1 - 25 of
556 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
H
Not yet recruiting
  • Breast Cancer
  • anlotinib and vinorelbine
  • Vinorelbine injection
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
2022-03-16
Mar 16, 2022
C
Recruiting
  • Anaplastic Large Cell Lymphoma
  • Vinorelbine
  • Vinorelbine
  • Shanghai, Shanghai, China
    Shanghai Children's Medical Center
2021-07-28
Jul 28, 2021
J
Recruiting
  • Rhabdomyosarcoma
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
2022-03-17
Mar 17, 2022
W
Completed
  • Mesothelioma
  • Vinorelbine
  • Active Symptom Control
  • Cardiff, United Kingdom
    Wales Cancer Trials Unit
2021-10-04
Oct 4, 2021
T
Completed
  • HER2-positive Advanced Breast Cancer
  • Pyrotinib Maleate
  • Vinorelbine
  • Tianjin, China
    Tianjin Cancer Hospital
2022-04-06
Apr 6, 2022
C
Recruiting
  • Metastatic Breast Cancer
  • Vinorelbine 40mg
  • +5 more
  • Beijing, Beijing, China
  • +1 more
2022-02-09
Feb 9, 2022
Z
Recruiting
  • Metastatic Breast Cancer
  • Cipterbin Combined With Vinorelbine
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
2021-11-11
Nov 11, 2021
A
Recruiting
  • Advanced Non-Small Cell Lung Cancer
  • Guangzhou, Guangdong, China
    Affiliated Cancer Hospital and Institute of Guangzhou Medical Un
2021-08-10
Aug 10, 2021
P
Recruiting
  • HER2-negative Breast Cancer
  • +5 more
  • Camrelizumab with vinorelbine and cisplatin
  • Beijing, Beijing, China
    Peking University First Hospital
2021-11-27
Nov 27, 2021
F
Completed
  • Breast Cancer
    • Shanghai, China
      Fudan University Shanghai Cancer Center
    2021-08-05
    Aug 5, 2021
    F
    Completed
    • Breast Cancer
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      2021-06-17
      Jun 17, 2021
      S
      Recruiting
      • Breast Cancer
      • +4 more
      • Pyrotinib 320mg + Vinorelbine
      • +2 more
      • Guangzhou, China
        Zhang Jingmin
      2020-10-22
      Oct 22, 2020
      U
      Active, not recruiting
      • Advanced Solid Tumours
      • +4 more
      • Durvalumab + Tremelimumab + metronomic Vinorelbine
      • Angers, France
      • +8 more
      2022-01-28
      Jan 28, 2022
      I
      Not yet recruiting
      • Non Hodgkin Lymphoma
      • Liposomal Mitoxantrone Hydrochloride dose level 1
      • +6 more
      • (no location specified)
      2022-03-17
      Mar 17, 2022
      H
      Terminated
      • Lung Adenocarcinoma
      • Otwock, Poland
      • +3 more
      2021-08-23
      Aug 23, 2021
      F
      Recruiting
      • Advanced Triple-Negative Breast Cancer
      • Shanghai, China
        Fudan University Cancer Hospital
      2020-07-21
      Jul 21, 2020
      V
      Terminated
      • Lung Cancer
      • Day 1: Cisplatin 75 mg/m2
      • +7 more
      • Vejle, Denmark
        Department of Oncology, Vejle Hospital
      2021-04-28
      Apr 28, 2021
      S
      Recruiting
      • Breast Cancer
      • Atezolizumab + Trastuzumab + Vinorelbine
      • Granada, Andalucía, Spain
      • +14 more
      2022-03-02
      Mar 2, 2022
      A
      Recruiting
      • Breast Cancer
      • Vinorelbine
      • +3 more
      • Birmingham, Alabama
      • +16 more
      2022-03-28
      Mar 28, 2022
      S
      Recruiting
      • Classical Hodgkin Lymphoma
      • Refractory or Relapsed Classical Hodgkin Lymphoma
      • PD-1 inhibitor
      • PD-1 inhibitor, gemcitabine, vinorelbine and doxorubicin liposome
      • Guangzhou, Guangdong, China
      • +2 more
      2021-04-17
      Apr 17, 2021
      J
      Completed
      • Lymphoma
      • rituximab
      • vinorelbine ditartrate
      • Los Angeles, California
        Jonsson Comprehensive Cancer Center, UCLA
      2020-07-30
      Jul 30, 2020